YSP Southeast Asia Holding Bhd
🇲🇾XKLS.7178MalaysiaHealthcare
PriceMYR 1.96-0.03 (-1.51%)
Latest anomalies
Neutral 1 detected in the last 120 days
- High: 16
- Medium: 4
- Low: 0
52-week low: the price is trading close to this level
Asset turnover: a sudden spike above its trailing quarter average
Cash conversion cycle: a sudden drop below its trailing quarter average
Days inventory outstanding: a sudden drop below its trailing quarter average
Days sales outstanding: a sudden drop below its trailing quarter average
Free with a Finzer account.
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Malaysia
Identity
- Exchange
- Bursa Malaysia . XKLS
- Type
- Stock
- ISIN
- MYL7178OO006
- CUSIP
- Not reported
Company
- Employees
- 1,380
- Headquarters
- Kuala Lumpur, Malaysia
- Website
- https://www.yspsah.com
Market
- Shares outstanding
- 141.8M
- Market cap
- MYR 278.02M
Highlights
- Market cap
- MYR 278.02M
- EPS LTM
- MYR 0.15
- P/E LTM
- 12.91calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 11.22%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- MYR 361.97M-0.71%down year on year
- Net income
- MYR 21.53M-30.89%down year on year
- Gross margin
- 42.62%-3.58%down year on year
- Free cash flow
- MYR 61.37M+74.22%up year on year
Latest news
News is not sourced for this exchange.
Business summary
YSP Southeast Asia Holding Bhd is a company in the healthcare sector, listed on Bursa Malaysia (Malaysia) under the ticker 7178. Its market capitalisation is MYR 278.02M, from 141.8M shares outstanding, as of . Across the 246 trading sessions to the shares traded between MYR 1.94 and MYR 2.20, and the last close of MYR 1.96 sits 8% of the way up that range. The company is headquartered in Kuala Lumpur, Malaysia, and employs about 1,380 people.
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-counter products, and herbal extracts; and offers management services. Y.S.P. Southeast Asia Holding Berhad was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.